ALT A Boston start-up takes an innovative approach to local anesthesia that combines safety, duration, and ease of use: https://bit.ly/3XjRW0u #startups

ALT #Robotics pioneer @IntuitiveSurg continues to be the dominant player with greater than 80% market share, nearly 10,000 da Vinci systems placed, and revenue growth in the mid to high teens, more than 20 years after it introduced the da Vinci robot: https://bit.ly/4hg6bum

ALT A panel of #medtech leaders opines on the current state of coding, coverage, and payment; Trump’s FDA retreats from the standards development process; a side-by-side comparison of device supply chain reporting rules in the US and EU; and more: https://bit.ly/43cQn8B

ALT Explore the barriers and opportunities learn directly from key decision-makers and read stories of companies that are persevering along every pathways of the #medtech market with @Market_Pathways. Learn why you need us for your market access strategy: https://bit.ly/46Q3lIz

ALT NEW EP. of @Market_Pathways Podcast: Following a robust 2024, the medical device sector continues to thrive in 2025 and remains somewhat insulated from dramatic shifts in #healthcare policies, at least in the short term: https://bit.ly/42nb0hG

ALT Be the expert in the room. Stay ahead of the curve in #medtech regulatory, reimbursement, and policy with Pathways' Document Depot: https://bit.ly/4kCLqMi

ALT Medtech has been accelerating innovation in product development with a record 124 new #devices approved by the FDA in 2023. Yet, this speed is not matched in #medtech trials, which can take up to seven years to complete. By Nicole Bongers, @veevasystems: https://bit.ly/3FnXkJU

ALT Are You Ahead of the Curve in #MedTech? Staying informed isn’t enough—you need strategic intelligence. @MedTechStrat delivers insights on market shifts, M&A, regulations, and innovation to help C-suite leaders stay ahead: https://bit.ly/3SKetBq

ALT #Medtech has mastered #innovation—but what about the launch? With tougher regs, longer R&D, and complex needs, success is harder than ever. A best-in-class launch can create 2x more value than a mediocre one. Source: @LEK_Consulting : https://bit.ly/3WEgJvQ

ALT Europe just enacted new requirements for device manufacturers to report anticipated product supply disruptions, and @US_FDA wants the US Congress to follow suit: https://bit.ly/4jygqwn #MedTech